Glazer Capital’s Drugs Made In America Acquisition II Corp Unit DMIIU Stock Holding History
Bought
Maintained
Sold
Other funds holding DMIIU
MI
SCM
Glazer Capital's DMIIU Position: Q4 2025 in Review
Glazer Capital sold out of Drugs Made In America Acquisition II Corp Unit (DMIIU) in Q4 2025, closing a stake of 2,350,000 shares — an estimated $23.4M sold.
Glazer Capital first reported a position in DMIIU in Q3 2025 and held it in 1 quarter. The position peaked at $23.4M in Q3 2025. 30 funds tracked by Wall St. Rank hold DMIIU as of Q4 2025.
- Glazer Capital reported no remaining Drugs Made In America Acquisition II Corp Unit position as of Q4 2025 after selling out during the quarter.
- Glazer Capital sold 2,350,000 Drugs Made In America Acquisition II Corp Unit shares in Q4 2025, an estimated $23.4M.
- Glazer Capital first reported a position in Drugs Made In America Acquisition II Corp Unit in Q3 2025 and held it in 1 quarter.
- Glazer Capital's Drugs Made In America Acquisition II Corp Unit position peaked at $23.4M in Q3 2025.
- 30 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Unit as of Q4 2025.
Based on Glazer Capital's 13F filing for Q4 2025, filed 13 Feb 2026.